| Antibody levels correlate with creatine kinase levels and strength in anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase–associated autoimmune myopathy JL Werner, L Christopher‐Stine, SR Ghazarian, KS Pak, JE Kus, NR Daya, ... Arthritis & Rheumatism 64 (12), 4087-4093, 2012 | 260 | 2012 |
| Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study B Warren, JS Pankow, K Matsushita, NM Punjabi, NR Daya, M Grams, ... The lancet Diabetes & endocrinology 5 (1), 34-42, 2017 | 213 | 2017 |
| Association of history of dizziness and long-term adverse outcomes with early vs later orthostatic hypotension assessment times in middle-aged adults SP Juraschek, N Daya, AM Rawlings, LJ Appel, ER Miller, BG Windham, ... JAMA internal medicine 177 (9), 1316-1323, 2017 | 158 | 2017 |
| Association of isolated diastolic hypertension as defined by the 2017 ACC/AHA blood pressure guideline with incident cardiovascular outcomes JW McEvoy, N Daya, F Rahman, RC Hoogeveen, RS Blumenthal, ... Jama 323 (4), 329-338, 2020 | 156 | 2020 |
| Frailty, kidney function, and polypharmacy: the atherosclerosis risk in communities (ARIC) study SH Ballew, Y Chen, NR Daya, JG Godino, BG Windham, ... American Journal of Kidney Diseases 69 (2), 228-236, 2017 | 142 | 2017 |
| Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study R Florido, NR Daya, CE Ndumele, S Koton, SD Russell, A Prizment, ... Journal of the American College of Cardiology 80 (1), 22-32, 2022 | 140 | 2022 |
| Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy DM Scholtens, MJ Muehlbauer, NR Daya, RD Stevens, AR Dyer, LP Lowe, ... Diabetes care 37 (1), 158-166, 2014 | 135 | 2014 |
| Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk KA Walker, J Chen, J Zhang, M Fornage, Y Yang, L Zhou, ME Grams, ... Nature Aging 1 (5), 473-489, 2021 | 120 | 2021 |
| Trends in insulin use and diabetes control in the US: 1988–1994 and 1999–2012 E Selvin, CM Parrinello, N Daya, RM Bergenstal Diabetes care 39 (3), e33-e35, 2016 | 115 | 2016 |
| Orthostatic hypotension in middle-age and risk of falls SP Juraschek, N Daya, LJ Appel, ER Miller III, BG Windham, L Pompeii, ... American journal of hypertension 30 (2), 188-195, 2017 | 106 | 2017 |
| Prevalence and risk factors of thyroid dysfunction in older adults in the community N Diab, NR Daya, SP Juraschek, SS Martin, JW McEvoy, UT Schultheiß, ... Scientific Reports 9 (1), 13156, 2019 | 95 | 2019 |
| Orthostatic hypotension and risk of clinical and subclinical cardiovascular disease in middle‐aged adults SP Juraschek, N Daya, LJ Appel, ER Miller III, JW McEvoy, K Matsushita, ... Journal of the American Heart Association 7 (10), e008884, 2018 | 95 | 2018 |
| Reproducibility and variability of protein analytes measured using a multiplexed modified aptamer assay A Tin, B Yu, J Ma, K Masushita, N Daya, RC Hoogeveen, CM Ballantyne, ... The journal of applied laboratory medicine 4 (1), 30-39, 2019 | 84 | 2019 |
| Thyroid function, cardiovascular risk factors, and incident atherosclerotic cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) Study SS Martin, N Daya, PL Lutsey, K Matsushita, A Fretz, JW McEvoy, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3306-3315, 2017 | 80 | 2017 |
| Kidney function and fracture risk: the Atherosclerosis Risk in Communities (ARIC) study NR Daya, A Voskertchian, ALC Schneider, S Ballew, MMA DeMarco, ... American Journal of Kidney Diseases 67 (2), 218-226, 2016 | 79 | 2016 |
| Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenon A Fava, PK Wung, FM Wigley, LK Hummers, NR Daya, SR Ghazarian, ... Arthritis care & research 64 (6), 925-929, 2012 | 69 | 2012 |
| Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study UT Schultheiss, N Daya, ME Grams, J Seufert, M Steffes, J Coresh, ... Nephrology Dialysis Transplantation 32 (11), 1874-1881, 2017 | 67 | 2017 |
| A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations UT Schultheiss, A Teumer, M Medici, Y Li, N Daya, L Chaker, G Homuth, ... The Journal of Clinical Endocrinology & Metabolism 100 (5), E799-E807, 2015 | 53 | 2015 |
| Confluence of epidemics of hepatitis C, diabetes, obesity, and chronic kidney disease in the United States population M Lazo, C Nwankwo, NR Daya, DL Thomas, SH Mehta, S Juraschek, ... Clinical Gastroenterology and Hepatology 15 (12), 1957-1964. e7, 2017 | 49 | 2017 |
| Isolated diastolic hypertension in the UK Biobank: comparison of ACC/AHA and ESC/NICE guideline definitions BP McGrath, P Kundu, N Daya, J Coresh, E Selvin, JW McEvoy, ... Hypertension 76 (3), 699-706, 2020 | 47 | 2020 |
